Epidemiology of Primary Liver Carcinoma

  • G. Wagner

Abstract

For several reasons it is difficult to make exact statements about the epidemiology of primary liver cancer:
  1. 1.

    Differential diagnosis of the various liver tumors is rather difficult

     
  2. 2.

    There are no corresponding data from many countries

     
  3. 3.

    The coding of the various subgroups of category 155 of the International Classification of Diseases (ICD) differs from country to country, as Aoki [2] was able to show with the aid of the WHO databank

     
  4. 4.

    Comparisons of present with past epidemiology are difficult or even impossible because, up to the 8th Revision of the ICD, malignant tumors of the liver and the gallbladder or bile duct were combined under a common code number. Only since 1968 (8th Revision of the ICD) have malignomas of the liver (ICD No. 155) been differentiated from those of the gallbladder (ICD No. 156).

     

Keywords

Hepatitis Europe Anemia Oncol Sarcoma 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Alpert ME, Hütt MSR, Wogan GN et al.: Association between aflatoxin content of food and hepatoma frequency in Uganda. Cancer 28 (1971) 253–260PubMedCrossRefGoogle Scholar
  2. 2.
    Aoki K: Cancer of the liver — international mortality trends. World Health Statist 31 (1978) 28–50Google Scholar
  3. 3.
    Beasley RP, Hwang LY, Lin CC, Chien CS: Hepatocellular carcinoma and hepatitis B virus. Lancet 1981, II, 1129–1132Google Scholar
  4. 4.
    Becker N, Frentzel-Beyme R, Wagner G: Krebsatlas der Bundesrepublik Deutschland — Altas of Cancer Mortality in the Federal Republic of Germany. Berlin Heidelberg New York Tokyo: Springer 1984Google Scholar
  5. 5.
    Bernstein MS, Hunter RL, Yachnin S: Hepatoma and peliosis hepatis developing in a patient with Fanconi’s anemia. New Engl J Med 284 (1971) 1135–1136PubMedCrossRefGoogle Scholar
  6. 6.
    Falk H: Liver. In: D. Schottenfeld and J.F. Fraumeni, Jr. (eds): Cancer Epidemiology and Prevention, pp 668–682. Philadelphia London Toronto: W. B. Saunders 1982.Google Scholar
  7. 7.
    Kew MC, Gear AJ, Baumgarten J et al.: Histocompatibility antigens in patients with hepa-tocellular carcinoma and their relationship to chronic hepatitis B virus infection in these patients. Gastroenterology 77 (1979) 537–539PubMedGoogle Scholar
  8. 8.
    Krain LS: Primary liver cancer in California. Oncology 28 (1973) 117–125PubMedCrossRefGoogle Scholar
  9. 9.
    Linsell CA Liver cell cancer — intervention studies. J Cancer Res Clin Oncol 99 (1981) 51–56PubMedCrossRefGoogle Scholar
  10. 10.
    Muir CS, Parkin DM: The world cancer burden: prevent or perish. Brit Med J 290 (1985) 5–6CrossRefGoogle Scholar
  11. 11.
    Parkin DM, Stjernwärd J, Muir CS: Estimates of the worldwide frequency of twelve major cancers. Bull WHO 62 (1984) 163–182PubMedGoogle Scholar
  12. 12.
    Pell S, D’Alonzo CA: A five-year mortality study of alcoholics. J Occup Med 15 (1973) 120–125PubMedGoogle Scholar
  13. 13.
    Popper H: Hepatic cancers in man: quantitative perspectives. Environm Res 19 (1979) 482–494CrossRefGoogle Scholar
  14. 14.
    Robinette CD, Hrubec Z, Fraumeni JF Jr: Chronic alcoholism and subsequent mortality in World War II veterans. Amer J Epidemiol 109 (1979) 687–700Google Scholar
  15. 15.
    Scheuer A, Lehmann F-G: Lebertumoren bei Therapie mit Kontrazeptiva und Anabolika. Internist 18 (1977) 208–214PubMedGoogle Scholar
  16. 16.
    Theilmann L, Gmelin K: Das primäre Leberzellkarzinom. Klinikarzt 14 (1985) 169–172Google Scholar
  17. 17.
    Van Kaick G, Muth H, Kaul A etal.: Results of the German Thorotrast Study. In J. D. Boyce, J. F. Fraumeni, Jr. (eds): Radiation Carcinogenesis: Epidemiology and Biological Significance. New York: Raven Press 1984Google Scholar
  18. 18.
    Waterhhouse J, Muir C, Shanmugaratnam K et al. Cancer Incidence in Five Continents, vol. IV. Lyon: IARC 1982Google Scholar

Copyright information

© Springer-Verlag 1987

Authors and Affiliations

  • G. Wagner

There are no affiliations available

Personalised recommendations